Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 2003, p. 383-386, Vol. 47, No. 1
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.1.383-386.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Division of Biological Sciences, The University of Montana, Missoula, Montana 59812
Received 2 April 2002/ Returned for modification 5 August 2002/ Accepted 1 October 2002
We isolated and characterized mutants of Bartonella bacilliformis that are resistant to the fluoroquinolone antibiotic ciprofloxacin, which targets the A subunit of DNA gyrase. Mutants had single point mutations in the gyrA gene that changed either Asp-90 to Gly or Asp-95 to Asn and had 3- or 16-fold higher resistance, respectively, to ciprofloxacin than did wild-type B. bacilliformis. Asp-95 is homologous to Asp-87 of Escherichia coli GyrA and is a common residue mutated in fluoroquinolone-resistant strains of other bacteria. This is the first report of a mutation at an Asp-90 homologue, which corresponds to Asp-82 in E. coli GyrA.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |